Literature DB >> 24647370

Transcription profiles of the ductus arteriosus in Brown-Norway rats with irregular elastic fiber formation.

Yi-Ting Hsieh1, Norika Mengchia Liu, Eriko Ohmori, Tomohiro Yokota, Ichige Kajimura, Toru Akaike, Toshio Ohshima, Nobuhito Goda, Susumu Minamisawa.   

Abstract

BACKGROUND: Patent ductus arteriosus (PDA) is one of the most common congenital cardiovascular defects in children. The Brown-Norway (BN) inbred rat presents a higher frequency of PDA. A previous study reported that 2 different quantitative trait loci on chromosomes 8 and 9 were significantly linked to PDA in this strain. Nevertheless, the genetic or molecular mechanisms underlying PDA phenotypes in BN rats have not been fully investigated yet. METHODS AND
RESULTS: It was found that the elastic fibers were abundant in the subendothelial area but scarce in the media even in the closed ductus arteriosus (DA) of full-term BN neonates. DNA microarray analysis identified 52 upregulated genes (fold difference >2.5) and 23 downregulated genes (fold difference <0.4) when compared with those of F344 control neonates. Among these genes, 8 (Tbx20, Scn3b, Stac, Sphkap, Trpm8, Rup2, Slc37a2, and RGD1561216) are located in chromosomes 8 and 9. Interestingly, it was also suggested that the significant decrease in the expression levels of the PGE2-specfic receptor, EP4, plays a critical role in elastogenesis in the DA.
CONCLUSIONS: BN rats exhibited dysregulation of elastogenesis in the DA. DNA microarray analysis identified the candidate genes including EP4 involved in the DNA phenotype. Further investigation of these newly identified genes will hopefully clarify the molecular mechanisms underlying the irregular formation of elastic fibers in PDA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647370     DOI: 10.1253/circj.cj-13-1029

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

1.  Genetic variants associated with patent ductus arteriosus in extremely preterm infants.

Authors:  John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray
Journal:  J Perinatol       Date:  2018-12-05       Impact factor: 2.521

2.  Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition.

Authors:  Ravi Goyal; Dipali Goyal; Lawrence D Longo; Ronald I Clyman
Journal:  Pediatr Res       Date:  2016-06-03       Impact factor: 3.756

Review 3.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

Review 4.  Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.

Authors:  Michael T Yarboro; Matthew D Durbin; Jennifer L Herington; Elaine L Shelton; Tao Zhang; Cris G Ebby; Jason Z Stoller; Ronald I Clyman; Jeff Reese
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

5.  Identification of differentially regulated genes in human patent ductus arteriosus.

Authors:  Pratik Parikh; Haiqing Bai; Michael F Swartz; George M Alfieris; David A Dean
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

Review 6.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

7.  Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.

Authors:  Nahid Waleh; Anne Marie Barrette; John M Dagle; Allison Momany; Chengshi Jin; Nancy K Hills; Elaine L Shelton; Jeff Reese; Ronald I Clyman
Journal:  J Pediatr       Date:  2015-08-08       Impact factor: 4.406

8.  Transcriptional profiles in the chicken ductus arteriosus during hatching.

Authors:  Toru Akaike; Satoko Shinjo; Eriko Ohmori; Ichige Kajimura; Nobuhito Goda; Susumu Minamisawa
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

9.  Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1.

Authors:  Kazuhiro Kuga; Yoichiro Kusakari; Ken Uesugi; Kentaro Semba; Takashi Urashima; Toru Akaike; Susumu Minamisawa
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

10.  Plasma Amino Acid Concentrations at Birth and Patent Ductus Arteriosus in Very and Extremely Preterm Infants.

Authors:  Maurice J Huizing; Moreyba Borges-Luján; Giacomo Cavallaro; Gema E González-Luis; Genny Raffaeli; Pilar Bas-Suárez; Jaap A Bakker; Rob M Moonen; Eduardo Villamor
Journal:  Front Pediatr       Date:  2021-02-11       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.